European Partnership One Health AntiMicrobial Resistance – EUP OHAMR

This first EUP OHAMR joint transnational call for projects will explore new treatments to tackle AMR. The call «Treatments and adherence to treatment protocols», involves 37 funding organisations from 28 different countries with an estimated total call budget of over EUR 31.000.000. The call is co-founded by the European Union.

Aim of the call:

To develop novel treatment protocols or alternative treatment strategies against infectious diseases and to improve, preserve and reinforce the clinical efficacy of the current treatment antimicrobials is vital. It is also necessary to identify barriers preventing the proper adherence of the end-users to the treatment protocols already in place.

Call topics:

• Topic 1
  • Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance
  • For the proposals having a Human Health interest, the proposed combination treatment should be directed against one of the bacterial or fungal pathogens included in the WHO priority lists:
    • WHO bacterial priority pathogens list
    • WHO fungal priority pathogens list
• Topic 2
  • Develop tools and methods to improve adherence to treatment protocols
  • Proposals addressing this topic should identify the reasons of poor adherence to treatment protocols (Human, Animal, Plant), and/or develop innovative tools (including digital tools) and methods (including sociological and behavioural approaches) to improve the adherence to treatment protocols and/or test and compare the efficiency of existing or innovative tools and methods on the adherence to treatment protocols
• Topic 3
  • Assess the impact of antimicrobials for veterinary and agricultural use in the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobial for human use
  • Proposals on this topic should also aim to improve the formulation, dosage, delivery, routes of administration and treatment regimens (including pharmacokinetics and pharmodynamics) currently used in the veterinary and agricultural sector, to decrease the risk of cross-resistence, or transmission to humans and the environment
    • WHO list of medically important antimicrobials

Deadline: 2 February 2026 for the pre-proposals